365 related articles for article (PubMed ID: 18495378)
1. Descriptive analysis of oligometastatic lesions treated with curative-intent stereotactic body radiotherapy.
Milano MT; Katz AW; Schell MC; Philip A; Okunieff P
Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1516-22. PubMed ID: 18495378
[TBL] [Abstract][Full Text] [Related]
2. A prospective pilot study of curative-intent stereotactic body radiation therapy in patients with 5 or fewer oligometastatic lesions.
Milano MT; Katz AW; Muhs AG; Philip A; Buchholz DJ; Schell MC; Okunieff P
Cancer; 2008 Feb; 112(3):650-8. PubMed ID: 18072260
[TBL] [Abstract][Full Text] [Related]
3. Analysis of patients with oligometastases undergoing two or more curative-intent stereotactic radiotherapy courses.
Milano MT; Philip A; Okunieff P
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):832-7. PubMed ID: 18760543
[TBL] [Abstract][Full Text] [Related]
4. Clinical outcomes of stereotactic brain and/or body radiotherapy for patients with oligometastatic lesions.
Inoue T; Katoh N; Aoyama H; Onimaru R; Taguchi H; Onodera S; Yamaguchi S; Shirato H
Jpn J Clin Oncol; 2010 Aug; 40(8):788-94. PubMed ID: 20406944
[TBL] [Abstract][Full Text] [Related]
5. The American Society for Therapeutic Radiology and Oncology (ASTRO) evidence-based review of the role of radiosurgery for malignant glioma.
Tsao MN; Mehta MP; Whelan TJ; Morris DE; Hayman JA; Flickinger JC; Mills M; Rogers CL; Souhami L
Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):47-55. PubMed ID: 16111571
[TBL] [Abstract][Full Text] [Related]
6. Oligometastatic breast cancer treated with curative-intent stereotactic body radiation therapy.
Milano MT; Zhang H; Metcalfe SK; Muhs AG; Okunieff P
Breast Cancer Res Treat; 2009 Jun; 115(3):601-8. PubMed ID: 18719992
[TBL] [Abstract][Full Text] [Related]
7. Hypofractionated stereotactic radiotherapy for the treatment of brain metastases.
Kwon AK; Dibiase SJ; Wang B; Hughes SL; Milcarek B; Zhu Y
Cancer; 2009 Feb; 115(4):890-8. PubMed ID: 19132728
[TBL] [Abstract][Full Text] [Related]
8. A matched-pair analysis comparing whole-brain radiotherapy plus stereotactic radiosurgery versus surgery plus whole-brain radiotherapy and a boost to the metastatic site for one or two brain metastases.
Rades D; Kueter JD; Pluemer A; Veninga T; Schild SE
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1077-81. PubMed ID: 18707817
[TBL] [Abstract][Full Text] [Related]
9. Stereotactic Body Radiation Therapy (SBRT) for lung metastases.
Okunieff P; Petersen AL; Philip A; Milano MT; Katz AW; Boros L; Schell MC
Acta Oncol; 2006; 45(7):808-17. PubMed ID: 16982544
[TBL] [Abstract][Full Text] [Related]
10. Stereotactic body radiotherapy for colorectal liver metastases: a pooled analysis.
Chang DT; Swaminath A; Kozak M; Weintraub J; Koong AC; Kim J; Dinniwell R; Brierley J; Kavanagh BD; Dawson LA; Schefter TE
Cancer; 2011 Sep; 117(17):4060-9. PubMed ID: 21432842
[TBL] [Abstract][Full Text] [Related]
11. Central thoracic lesions treated with hypofractionated stereotactic body radiotherapy.
Milano MT; Chen Y; Katz AW; Philip A; Schell MC; Okunieff P
Radiother Oncol; 2009 Jun; 91(3):301-6. PubMed ID: 19329210
[TBL] [Abstract][Full Text] [Related]
12. Observation of a dose-control relationship for lung and liver tumors after stereotactic body radiation therapy.
McCammon R; Schefter TE; Gaspar LE; Zaemisch R; Gravdahl D; Kavanagh B
Int J Radiat Oncol Biol Phys; 2009 Jan; 73(1):112-8. PubMed ID: 18786780
[TBL] [Abstract][Full Text] [Related]
13. [Therapeutic analysis of stereotactic radiotherapy for 39 patients with lung metastasis].
Wu SX; Deng ML; Bao Y; Wang HY; Gao YH; Li FY; Huang SM
Ai Zheng; 2006 Jul; 25(7):880-4. PubMed ID: 16831282
[TBL] [Abstract][Full Text] [Related]
14. Relationship between volume, dose and local control in stereotactic radiosurgery of brain metastasis.
Molenaar R; Wiggenraad R; Verbeek-de Kanter A; Walchenbach R; Vecht C
Br J Neurosurg; 2009 Apr; 23(2):170-8. PubMed ID: 19306173
[TBL] [Abstract][Full Text] [Related]
15. Linear accelerator stereotactic radiosurgery for metastatic brain tumors: 17 years of experience at the University of Florida.
Swinson BM; Friedman WA
Neurosurgery; 2008 May; 62(5):1018-31; discussion 1031-2. PubMed ID: 18580799
[TBL] [Abstract][Full Text] [Related]
16. Survival benefit of stereotactic radiosurgery for metastatic brain tumors in patients with controlled primary lesions and no other distant metastases.
Niibe Y; Karasawa K; Nakamura O; Shinoura N; Okamoto K; Yamada R; Fukino K; Tanaka Y
Anticancer Res; 2003; 23(5b):4157-9. PubMed ID: 14666618
[TBL] [Abstract][Full Text] [Related]
17. Stereotactic body radiotherapy for oligometastatic lung tumors.
Norihisa Y; Nagata Y; Takayama K; Matsuo Y; Sakamoto T; Sakamoto M; Mizowaki T; Yano S; Hiraoka M
Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):398-403. PubMed ID: 18374506
[TBL] [Abstract][Full Text] [Related]
18. Whole-brain radiotherapy versus stereotactic radiosurgery for patients in recursive partitioning analysis classes 1 and 2 with 1 to 3 brain metastases.
Rades D; Pluemer A; Veninga T; Hanssens P; Dunst J; Schild SE
Cancer; 2007 Nov; 110(10):2285-92. PubMed ID: 17922523
[TBL] [Abstract][Full Text] [Related]
19. Stereotactic body radiation therapy using three fractions for isolated lung recurrence from colorectal cancer.
Kim MS; Yoo SY; Cho CK; Yoo HJ; Choi CW; Seo YS; Kang JK; Lee DH; Hwang DY; Moon SM; Kim MS; Kang HJ; Kim YH
Oncology; 2009; 76(3):212-9. PubMed ID: 19218825
[TBL] [Abstract][Full Text] [Related]
20. Modeling growth kinetics and statistical distribution of oligometastases.
Withers HR; Lee SP
Semin Radiat Oncol; 2006 Apr; 16(2):111-9. PubMed ID: 16564446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
